Drugs.com - Pharma Industry News

2018 to 2022 Saw Increase in GLP-1 Receptor Agonist Use in Adults Without Diabetes

THURSDAY, April 10, 2025 -- Among U.S. adults without diabetes, the use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) increased from 2018 to 2022, reaching annual prevalence of 0.4 percent in 2022, according to a study published online...

Apr 10, 2025 - 18:32
 0
2018 to 2022 Saw Increase in GLP-1 Receptor Agonist Use in Adults Without Diabetes
THURSDAY, April 10, 2025 -- Among U.S. adults without diabetes, the use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) increased from 2018 to 2022, reaching annual prevalence of 0.4 percent in 2022, according to a study published online...
Read More

Tags:

Previous Article

Environmental Surfaces, Clinician Hands Play Role in C. Difficile Transmission i...

Next Article

One in 10 With Substance Use Disorder Report Past-Year Hospitalizations

Related Posts

People With Disabilities Often Feel Disrespected by Health Care Workers

People With Disabilities Often Feel Disrespected by Hea...

Mar 10, 2025  0

Stimulant Involvement in Opioid OD Death Higher for Those in Physically Demanding Jobs

Stimulant Involvement in Opioid OD Death Higher for Tho...

Apr 1, 2025  0

Excessive Use of Overtime, Agency Nurse Hours Increase Rates of Patient Safety Indicators

Excessive Use of Overtime, Agency Nurse Hours Increase ...

Apr 9, 2025  0